A detailed history of Walled Lake Planning & Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Walled Lake Planning & Wealth Management, LLC holds 2,585 shares of ABBV stock, worth $526,176. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,585
Previous 2,565 0.78%
Holding current value
$526,176
Previous $467,000 5.14%
% of portfolio
0.2%
Previous 0.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $3,095 - $3,615
20 Added 0.78%
2,585 $443,000
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $319 - $364
2 Added 0.08%
2,565 $467,000
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $352,668 - $397,188
2,563 New
2,563 $397,000
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $358,500 - $455,770
-2,605 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $6.87 Million - $8.52 Million
-52,041 Reduced 95.23%
2,605 $422,000
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $144,063 - $182,282
-1,341 Reduced 2.4%
54,646 $7.4 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $90,333 - $102,542
849 Added 1.54%
55,987 $6.04 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $36,087 - $40,203
343 Added 0.63%
55,138 $6.21 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $1,227 - $1,351
-12 Reduced 0.02%
54,795 $5.93 Million
Q4 2020

Feb 19, 2021

SELL
$80.49 - $108.67 $8,531 - $11,519
-106 Reduced 0.19%
54,807 $5.87 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $2,491 - $2,924
29 Added 0.05%
54,913 $4.81 Million
Q2 2020

Aug 18, 2020

SELL
$73.37 - $98.18 $63,758 - $85,318
-869 Reduced 1.56%
54,884 $5.39 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $103,458 - $156,855
1,604 Added 2.96%
55,753 $4.25 Million
Q4 2019

May 15, 2020

BUY
$72.13 - $90.25 $3.91 Million - $4.89 Million
54,149 New
54,149 $4.79 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Walled Lake Planning & Wealth Management, LLC Portfolio

Follow Walled Lake Planning & Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walled Lake Planning & Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walled Lake Planning & Wealth Management, LLC with notifications on news.